TELA Bio, Inc.TELANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+31.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+31.9%/yr
vs -22.8%/yr prior
Acceleration
+54.7pp
Accelerating
Percentile
P83
Within normal range
vs 3Y Ago
2.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 16.82% |
| Q2 2025 | 13.28% |
| Q1 2025 | -25.35% |
| Q4 2024 | 10.80% |
| Q3 2024 | 19.06% |
| Q2 2024 | -139.74% |
| Q1 2024 | 60.69% |
| Q4 2023 | -20.60% |
| Q3 2023 | 1.75% |
| Q2 2023 | 7.93% |
| Q1 2023 | -19.23% |
| Q4 2022 | 0.51% |
| Q3 2022 | 7.33% |
| Q2 2022 | -3.99% |
| Q1 2022 | -28.61% |
| Q4 2021 | -6.06% |
| Q3 2021 | 1.29% |
| Q2 2021 | -0.58% |
| Q1 2021 | -7.74% |
| Q4 2020 | 1.69% |
| Q3 2020 | -32.85% |
| Q2 2020 | 20.51% |
| Q1 2020 | -11.55% |
| Q4 2019 | -51.09% |
| Q3 2019 | 10.33% |
| Q2 2019 | 16.99% |
| Q1 2019 | 5.78% |
| Q4 2018 | -117.83% |
| Q3 2018 | 48.28% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |